Luye Pharma Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications. | ![]() Hisamitsu Pharmaceutical Hisamitsu Pharmaceutical (久光製藥株式會社) is a company manufacturing external analgesic and anti-inflammatory preparations, such as medicated plasters, gels, sprays, etc. | ![]() Dragonfly Dragonfly Therapeutics is a company developing drugs targeted at natural killer cells and other cells of the body's innate immune system to eliminate cancer. | ||
Founding Date | Founding Date 1994 | Founding Date 1847 | Founding Date 2015 | Founding Date 1998 |
Type | Type Public | Type Public | Type Private | Type Public |
Tags | ||||
Locations | Locations CN HQ | Locations Waltham, US HQ | Locations Seongnam-si, KR HQ | |
Employees | Employees 5,150 | Employees 2,759 | Employees 109 | Employees 50 |
Financial | ||||
Revenue (est.) | Revenue (est.) ¥6.3b (FY, 2025) | Revenue (est.) ¥163b (FY, 2026) | Revenue (est.) N/A | Revenue (est.) ₩99.8b (FY, 2025) |
Cost of goods | Cost of goods ¥1.3b (FY, 2025) | Cost of goods ¥59.9b (FY, 2026) | Cost of goods N/A | Cost of goods ₩438.8m (FY, 2025) |
Gross profit | Gross profit ¥5.1b (FY, 2025) | Gross profit ¥103.2b (FY, 2026) | Gross profit N/A | Gross profit ₩100b (FY, 2025) |
Net income | Net income ¥705.7m (FY, 2025) | Net income ¥19.6b (FY, 2026) | Net income N/A | Net income ₩54.4b (FY, 2025) |

Hisamitsu Pharmaceutical (久光製藥株式會社) is a company manufacturing external analgesic and anti-inflammatory preparations, such as medicated plasters, gels, sprays, etc.
View company
Dragonfly Therapeutics is a company developing drugs targeted at natural killer cells and other cells of the body's innate immune system to eliminate cancer.
View company
Oscotec is a clinical stage drug discovery and development company.
View company